131 related articles for article (PubMed ID: 21839060)
1. Vascularity of nongynecological leiomyosarcoma depends on colony-stimulating factor 1 but not on vascular endothelial growth factor.
Kubota Y; Suda T
Am J Pathol; 2011 Oct; 179(4):1591-3. PubMed ID: 21839060
[TBL] [Abstract][Full Text] [Related]
2. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
Espinosa I; Edris B; Lee CH; Cheng HW; Gilks CB; Wang Y; Montgomery KD; Varma S; Li R; Marinelli RJ; West RB; Nielsen T; Beck AH; van de Rijn M
Am J Pathol; 2011 Oct; 179(4):2100-7. PubMed ID: 21854753
[TBL] [Abstract][Full Text] [Related]
3. Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
Espinosa I; Beck AH; Lee CH; Zhu S; Montgomery KD; Marinelli RJ; Ganjoo KN; Nielsen TO; Gilks CB; West RB; van de Rijn M
Am J Pathol; 2009 Jun; 174(6):2347-56. PubMed ID: 19443701
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
5. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling.
Rego SL; Helms RS; Dréau D
Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
[TBL] [Abstract][Full Text] [Related]
7. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.
Kono H; Fujii H; Furuya S; Hara M; Hirayama K; Akazawa Y; Nakata Y; Tsuchiya M; Hosomura N; Sun C
World J Gastroenterol; 2016 Oct; 22(39):8779-8789. PubMed ID: 27818593
[TBL] [Abstract][Full Text] [Related]
8. The possible mechanisms of tumor progression via CSF-1/CSF-1R pathway activation.
Huang L; Xu X; Hao Y
Rom J Morphol Embryol; 2014; 55(2 Suppl):501-6. PubMed ID: 25178319
[TBL] [Abstract][Full Text] [Related]
9. Paracrine regulation of vascular endothelial growth factor--a expression during macrophage-melanoma cell interaction: role of monocyte chemotactic protein-1 and macrophage colony-stimulating factor.
Varney ML; Olsen KJ; Mosley RL; Singh RK
J Interferon Cytokine Res; 2005 Nov; 25(11):674-83. PubMed ID: 16318581
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.
Suzuki K; Sun R; Origuchi M; Kanehira M; Takahata T; Itoh J; Umezawa A; Kijima H; Fukuda S; Saijo Y
Mol Med; 2011; 17(7-8):579-87. PubMed ID: 21424106
[TBL] [Abstract][Full Text] [Related]
11. Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis.
Yu JL; Rak JW
Breast Cancer Res; 2003; 5(2):83-8. PubMed ID: 12631386
[TBL] [Abstract][Full Text] [Related]
12. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
[TBL] [Abstract][Full Text] [Related]
13. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.
Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W
Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982
[TBL] [Abstract][Full Text] [Related]
14. High oxygen tension prolongs the survival of osteoclast precursors via macrophage colony-stimulating factor.
Yamasaki N; Tsuboi H; Hirao M; Nampei A; Yoshikawa H; Hashimoto J
Bone; 2009 Jan; 44(1):71-9. PubMed ID: 18973838
[TBL] [Abstract][Full Text] [Related]
15. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
[TBL] [Abstract][Full Text] [Related]
16. The role of hypoxia related angiogenesis in uterine smooth muscle tumors.
Uluer ET; Inan S; Ozbilgin K; Karaca F; Dicle N; Sancı M
Biotech Histochem; 2015 Feb; 90(2):102-10. PubMed ID: 25225843
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes.
Zheng Q; Li X; Cheng X; Cui T; Zhuo Y; Ma W; Zhao X; Zhao P; Liu X; Feng W
Tumour Biol; 2017 Feb; 39(2):1010428317692232. PubMed ID: 28240048
[TBL] [Abstract][Full Text] [Related]
18. Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas.
Verheul HM; Hoekman K; Lupu F; Broxterman HJ; van der Valk P; Kakkar AK; Pinedo HM
Clin Cancer Res; 2000 Jan; 6(1):166-71. PubMed ID: 10656446
[TBL] [Abstract][Full Text] [Related]
19. MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line.
Alias C; Rocchi L; Ribatti D; Caraffi S; D'Angelo A; Perris R; Mangieri D
J Cell Mol Med; 2015 Sep; 19(9):2098-107. PubMed ID: 26010680
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
McMeekin DS; Sill MW; Darcy KM; Stearns-Kurosawa DJ; Webster K; Waggoner S; Benbrook D
Gynecol Oncol; 2007 Sep; 106(3):596-603. PubMed ID: 17597196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
